Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04527952 · ClinicalTrials.gov registry record · NA
The Fasting and Shifted Timing (FAST) of Eating Study
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04527952: Completed NA study, sponsored by University of South Carolina.
NCT04527952 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04527952, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The aim of this study is to assess peoples' satisfaction with their diet based on adhering to three different meal-timing protocols for one week each: (1) Time-restricted feeding (TRF); (2) Intermittent fasting (IF); and (3) Alternate day fasting (ADF). The overall goal of this study is to determine if people would find it easy or difficult to follow these diet protocols for the purpose of weight management.
Primary Outcome
We will assess weight loss via self-report after 1 week on diet #1
Interventions
- BEHAVIORAL Online handouts describing how to follow each diet for 1 week each
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-06-19 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
What the finished NCT04527952 record still lists
NCT04527952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Online handouts describing how to follow each diet for 1 week each is the first listed.
NCT04527952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04527952 about?
NCT04527952 is a clinical study titled "The Fasting and Shifted Timing (FAST) of Eating Study". The aim of this study is to assess peoples' satisfaction with their diet based on adhering to three different meal-timing protocols for one week each: (1) Time-restricted feeding (TRF); (2) Intermittent fasting (IF); and (3) Alternate day fasting (ADF). The overall goal of this study is to determine...
What is the current status of trial NCT04527952?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-06-19. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT04527952?
The interventions under investigation include: Online handouts describing how to follow each diet for 1 week each (BEHAVIORAL).
Who is sponsoring clinical trial NCT04527952?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04527952's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI